LeukoSite develops antibody treatment and care.
Business Model:
Revenue: $0
Employees: 51-200
LeukoSite was acquired by
Millennium Pharmaceuticals.
The acquisition happend on 1999-10-17.
Details of the transaction were not public
Address:
City: Cambridge
State: Massachusetts
Zip:
Country: United States
LeukoSite provides treatment and cares for inflammatory, autoimmune, cancer applications, and viral diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/27/1997
Ticker Symbol:
LKST
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/1997 | Post-IPO Equity | 1 | - |
SV Health Investors SV Health Investors |
7/1998 | Post-IPO Equity | $12M | 1/1997 | Post-IPO Equity | 1 | - |
SV Health Investors SV Health Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|